All 198 cited references are listed at the end of the document. “
“Latest update: July 2010. Next update: Not indicated. Patient group: Adults and children presenting with non-cystic fibrosis bronchiectasis. These are patients with symptoms of persistent or recurrent bronchial sepsis related to irreversibly damaged and dilated bronchi. Intended audience: Clinicians who manage patients with non-CF bronchiectasis.
Additional versions: Nil. Expert working group: The guideline group consisted of 21 experts, including adult physicians, paediatricians, specialist nurses, http://www.selleckchem.com/products/LY294002.html physiotherapists, microbiologists, a general practitioner, surgeon, immunologist, radiologist, and a patient representative. Funded by: Not indicated. Consultation with: External peer reviewers were consulted. Approved by: British Thoracic Society. Location: Pasteur MC, Bilton D, Hill AT (2010) Guidelines for non-CF bronchiectasis. Thorax 65(S1): 1-64. http://www.brit-thoracic.org.uk/Clinical-Information/Bronchiectasis/Bronchiectasis-Guideline-(non-CF).aspx Description:This 64 page document presents evidence-based clinical practice guidelines on the background, potential causes, clinical assessments, investigations, and management of adults and children with non-CF bronchiectasis. It begins with a 6-page summary of all recommendations. The guidelines then provide information on the potential underlying causes of bronchiectasis, and its associations
with other pathologies. The clinical presentation in both adults and children is detailed, and evidence for diagnostic investigations is provided, such Talazoparib mw as immunological tests, radiological investigations, sputum microbiology, and lung function tests. General principles of management are indicated, followed by evidence for physiotherapy in this condition. This includes interventions such as airway clearance techniques, active cycle of breathing techniques, manual techniques, positive expiratory
pressure, autogenic drainage, high frequency chest wall oscillation, and exercise. The evidence for the use of airway pharmacotherapy such as mucolytics, hyperosmolar agents, bronchodilators, inhaled corticosteroids and leukotriene receptor antagonists are detailed, followed by evidence for Non-specific serine/threonine protein kinase management using antibiotics. Recommendations are given for assessments needed in patients with acute exacerbations in the outpatient and inpatient sector, with criteria provided to determine when inpatient treatment of an acute exacerbation is required. Finally, evidence for surgery, complications and management of the advanced disease is provided. All 549 cited references are provided. “
“This textbook primarily offers clinicians a multidisciplinary approach to the diagnosis and management of headache. Because fewer chapters are devoted to the diagnosis and management of orofacial pain and bruxism, this appears to be a secondary but related focus taken by the book’s editors.